Filter by: Subject

Filter by: Subject

Results Per Page:

Rheumatoid arthritis (RA) (7)
Neutrophils (5)
Platelets (5)
SDG-03: Good health and well-being (5)
Calcium (4)
Reactive oxygen species (4)
CD62P (3)
Cytokines (3)
Human immunodeficiency virus (HIV) (3)
Inflammation (3)
Rheumatoid arthritis (3)
Adenosine 50-diphosphate (2)
Calcium fluxes (2)
Community-acquired pneumonia (2)
Coronavirus disease 2019 (COVID-19) (2)
COVID-19 pandemic (2)
Cytosolic calcium (2)
Dolutegravir (DTG) (2)
Elastase (2)
Innate immunity (2)
P-selectin (2)
People living with HIV (PLHIV) (2)
Phosphatidylinositol 3-kinase (2)
Phospholipase C (2)
Pneumococcus (2)
Pneumonia (2)
Pro-inflammatory activity (2)
South Africa (2)
South Africa (SA) (2)
Streptococcus pneumoniae (2)
Tobacco usage (2)
Tuberculosis (TB) (2)
5-lipoxygenase (1)
Adenosine-5′-triphosphate (1)
Adolescents (1)
Airway epithelial cells (1)
Airway microbiota (1)
Anaemia (1)
Anti-CEP-1 (1)
Anti-citrullinated peptide (anti-CCP) (1)
Anti-citrullinated peptide antibodies (1)
Anti-citrullinated peptide antibodies (ACPAs) (1)
Anti-citrullinated peptide/protein antibodies (1)
Anti-CTLA-4 antibodies (1)
Anti-cyclic citrullinated peptide antibodies (ACPA) (1)
Anti-inflammatory activity (1)
Anti-inflammatory agents (1)
Anti-MCV (1)
Anti-PDL-1 monoclonal antibodies (1)
Anti-Sa (1)
Antibiotic properties (1)
Antibiotics (1)
Anticyclic citrullinated peptide antibodies (1)
Antimicrobial activities (1)
Antimicrobial activity (1)
Atmospheric pollution (1)
Autoantibodies (1)
Autoantibody (1)
Autoimmune disease (1)
Bacteria (1)
Bedaquiline (1)
Benefits (1)
Biological transport (1)
Biomarkers (1)
C-reactive protein (1)
Calcium -- Physiological transport (1)
Calcium -- Research (1)
Calcium homeostasis (1)
Calcium ionophore (1)
Cardiovascular disease (CVD) (1)
Cardiovascular risk (1)
CD25 (1)
CD86 (1)
Cell viability (1)
Chemical inhibitors (1)
Chemical toxicants (1)
Chemiluminescence (1)
Chemoattractant (1)
Chronic granulomatous disease (1)
Chronic inflammation (1)